We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+0.92%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.16B
AUM Growth
-$38.5M
Cap. Flow
-$16.1M
Cap. Flow %
-1.39%
Top 10 Hldgs %
4.12%
Holding
2,179
New
583
Increased
522
Reduced
502
Closed
562

Sector Composition

Rank Sector Weight
1 Healthcare 16.3%
2 Technology 15.76%
3 Financials 13.46%
4 Industrials 12.71%
5 Consumer Discretionary 10.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RWT
1201
Redwood Trust
RWT
$594M
$283K 0.02%
+51,197
New +$281K
SHO icon
1202
Sunstone Hotel Investors
SHO
$2.06B
$283K 0.02%
31,617
-30,143
-49% -$276K
CPRX
1203
DELISTED
Catalyst Pharmaceutical
CPRX
$282K 0.02%
+12,090
New +$269K
DELL icon
1204
Dell
DELL
$293B
$282K 0.02%
2,243
-1,128
-33% -$159K
HRB icon
1205
H&R Block
HRB
$5.86B
$282K 0.02%
6,467
-1,802
-22% -$84.2K
IMUX icon
1206
Immunic
IMUX
$195M
$282K 0.02%
52,746
+33,454
+173% +$245K
VIOO icon
1207
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.33B
$282K 0.02%
+2,538
New +$282K
MCD icon
1208
McDonald's
MCD
$195B
$280K 0.02%
916
-2,503
-73% -$767K
RRBI icon
1209
Red River Bancshares
RRBI
$659M
$280K 0.02%
3,925
-5,052
-56% -$345K
TRVG
1210
trivago
TRVG
$397M
$280K 0.02%
96,415
+65,129
+208% +$198K
PJP icon
1211
Invesco Pharmaceuticals ETF
PJP
$498M
$279K 0.02%
+2,666
New +$268K
TARA icon
1212
Protara Therapeutics
TARA
$232M
$279K 0.02%
52,332
-49,156
-48% -$273K
EBF icon
1213
Ennis
EBF
$564M
$278K 0.02%
15,441
-27,050
-64% -$472K
NDSN icon
1214
Nordson
NDSN
$17.3B
$277K 0.02%
+1,153
New +$271K
SLQT icon
1215
SelectQuote
SLQT
$121M
$277K 0.02%
196,422
+158,278
+415% +$265K
GDX icon
1216
VanEck Gold Miners ETF
GDX
$27.4B
$276K 0.02%
3,214
-2,058
-39% -$163K
EVER icon
1217
EverQuote
EVER
$906M
$275K 0.02%
+10,203
New +$247K
APLD icon
1218
Applied Digital
APLD
$8.41B
$274K 0.02%
11,190
+527
+5% +$15.2K
AMRX icon
1219
Amneal Pharmaceuticals
AMRX
$5.79B
$273K 0.02%
21,657
-38,893
-64% -$445K
HCI icon
1220
HCI Group
HCI
$2.41B
$273K 0.02%
+1,425
New +$268K
DUK icon
1221
Duke Energy
DUK
$97.3B
$272K 0.02%
2,324
+550
+31% +$67.2K
FBIN icon
1222
Fortune Brands Innovations
FBIN
$6.06B
$272K 0.02%
5,430
+728
+15% +$36.5K
GASS icon
1223
StealthGas
GASS
$319M
$272K 0.02%
38,812
+8,853
+30% +$59.5K
TMDX icon
1224
Transmedics
TMDX
$2.91B
$272K 0.02%
2,233
-3,748
-63% -$470K
XERS icon
1225
Xeris Biopharma Holdings
XERS
$1.45B
$272K 0.02%
34,665
-34,051
-50% -$268K

Similar funds

GSA Capital Partners's Q4 2025 Portfolio in Review

As of Q4 2025, GSA Capital Partners held 2,179 positions worth $1.16B, down 3.2% from $1.2B the previous quarter. Its ten largest holdings account for 4.1% of the portfolio.

GSA Capital Partners's Q4 2025 filing shows 583 new, 522 increased, 502 reduced and 562 closed positions. Its largest new stake was iShares Floating Rate Bond ETF: 137,329 shares worth $6.99M. The largest sale was Nuvation Bio, an estimated $6.32M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • GSA Capital Partners's largest Q4 2025 buy was iShares Floating Rate Bond ETF: 137,329 shares worth $6.99M.
  • GSA Capital Partners added most to Remitly in Q4 2025, an estimated $4.91M increase.
  • GSA Capital Partners's biggest Q4 2025 reduction was Nuvation Bio, cutting an estimated $6.32M.
  • GSA Capital Partners fully exited Jefferies Financial Group in Q4 2025, selling an estimated $3.77M.
  • GSA Capital Partners's ten largest holdings make up 4.1% of its $1.16B portfolio in Q4 2025.
  • GSA Capital Partners opened 583 new positions and closed 562 in Q4 2025.
  • GSA Capital Partners's portfolio value fell 3.2% quarter-over-quarter to $1.16B.

Based on GSA Capital Partners's 13F filing for Q4 2025, filed 6 Feb 2026.